Clinical Trial Update: Revascularization in Heart Failure Trial - REHEAT 2 [Phase 4]

View source ↗

Summary

Clinical trial update for the REHEAT 2 Phase 4 study evaluating revascularization strategies in ischemic heart disease, including patients with reduced left ven…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction
• Ischemic Heart Disease

Snippet

Sponsor: Ministry of Science and Higher Education, Poland | Conditions: Left Ventricular Ejection Fraction, Myocardial Revascularization | Phase 4 | Status: UNKNOWN